Back to Search
Start Over
ImStem obtains from AgeX a royalty-bearing sublicense for ESC line ESI-053
- Source :
- The Fly. October 28, 2020
- Publication Year :
- 2020
-
Abstract
- AgeX Therapeutics and ImStem Biotechnology announced that ImStem has obtained from AgeX a non-exclusive, royalty-bearing sublicense to use AgeX's clinical-grade ESC line ESI-053 to derive ImStem's investigational MSC product candidate [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.639698387